Literature DB >> 24952408

Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancer.

Nadeem Abu-Rustum, Dennis Chi, Robert L Coleman, Josep M del Campo, Christina Fotopoulou, Michael Frumovitz, David M Gershenson, Antonio Gonzalez, Anuja Jhingran, Jonathan Ledermann, Andrea Mariani, Mansoor Mirza, Ana Oaknin, Pedro T Ramirez, Kathleen M Schmeler, Anil K Sood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24952408     DOI： 10.1016/j.ygyno.2014.04.042

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  4 in total

1.  The clinical significance of occult gynecologic primary tumours in metastatic cancer.

Authors:  M B Hannouf; E Winquist; S M Mahmud; M Brackstone; S Sarma; G Rodrigues; P K Rogan; J S Hoch; G S Zaric
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

2.  The Futility of Systematic Lymphadenectomy in Early-Stage Low-grade Endometrial Cancer.

Authors:  Nidhi Nayyar; Prerna Lakhwani; Ashish Goel; Pankaj Kr Pande; Kapil Kumar
Journal:  Indian J Surg Oncol       Date:  2018-04-18

3.  The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II.

Authors:  Ingiridur Skirnisdottir; Tomas Seidal; Helena Åkerud
Journal:  Int J Oncol       Date:  2016-01-12       Impact factor: 5.650

4.  The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study.

Authors:  Malek B Hannouf; Eric Winquist; Salaheddin M Mahmud; Muriel Brackstone; Sisira Sarma; George Rodrigues; Peter K Rogan; Jeffrey S Hoch; Gregory S Zaric
Journal:  Pharmacoecon Open       Date:  2018-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.